View source for Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial
Jump to navigation
Jump to search
You do not have permission to edit this page, for the following reason:
You can view and copy the source of this page.